Artificial intelligence to detect early Alzheimer's signs
Part of Brain & nervous system, Mental health clinical trials.
This study uses artificial intelligence to look for early signs of Alzheimer's disease in people who have memory concerns but normal test scores. It may help identify who is at risk earlier.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 40 years or older.
- You have noticed a persistent decline in your memory or thinking compared to your previous normal state, but it is not due to a sudden event.
- You perform normally on standard memory and thinking tests for your age, gender, and education.
- You speak Italian as your native language.
- You have been on stable medication for at least 4 weeks before joining.
- You agree to participate and sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a noninvasive magnetic brain stimulation treatment can slow down cognitive decline in people with early Alzheimer's disease. You'll receive daily sessions over several weeks, and the goal is to see if it helps preserve memory and thinking skills.
This trial tests whether transcranial magnetic stimulation (TMS), a noninvasive brain treatment, can help people with early Alzheimer's or mild cognitive impairment. It aims to see if the treatment is safe and effective for slowing memory decline.
This study uses a noninvasive brain stimulation technique called TMS to see if it can slow cognitive decline in older adults who are healthy or have very early signs of Alzheimer's disease. It aims to improve memory and thinking.
This study tests whether a new type of brain stimulation (called repetitive transcranial magnetic stimulation, or rTMS) with a larger coil can improve memory and thinking in people with mild to moderate Alzheimer's disease. It involves multiple sessions of rTMS and MRI scans.
This trial is testing whether a non-invasive brain stimulation treatment, called transcranial magnetic stimulation (using magnetic fields to activate brain cells), can help improve memory and thinking in people with Alzheimer's disease. It is a potential option for those looking to explore additional treatment approaches.
This trial studies a “closed-loop” brain stimulation approach to improve symptoms in people with early Alzheimer’s-related memory problems. It may help by delivering stimulation based on your brain signals, if you meet the safety and diagnosis requirements.
Hear when a new Mild Cognitive Impairment trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.